1. Current place of monoamine oxidase inhibitors in the treatment of depression;Shulman;CNS Drugs,2013
2. MAO-inhibitors in Parkinson’s disease;Riederer;Exp. Neurobiol.,2011
3. Non-P450 mediated oxidative metabolism of xenobiotics in drug metabolizing enzymes: cytochrome P450 and other enzymes in drug discovery and development;Lee;FontisMedia SA,2003
4. Inactivation of cytochrome P4502B1 by the monoamine oxidase inhibitors R-(−)-deprenyl and clorgyline;Sharma;Drug Metab. Dispos.,1996
5. Formation of a metabolic intermediate complex of cytochrome P4502B1 by clorgyline;Sharma;Drug Metab. Dispos.,1996